首页 > 最新文献

Journal of Interventional Medicine最新文献

英文 中文
A cross-sectional study on coronary artery disease diagnosis in patients with peripheral artery disease 外周动脉病变患者冠状动脉病变诊断的横断面研究
Q3 Medicine Pub Date : 2022-11-01 DOI: 10.1016/j.jimed.2022.09.005
Jai Bharat Bhalke , Shirish Hiremath , C.N. Makhale

Purpose

Compared with healthy individuals, patients with peripheral artery disease (PAD) generally have a very high risk of subclinical Coronary artery disease (CAD) and cardiovascular events. To determine the correlation between CAD in PAD patients, thereby promoting the lifetime of PAD patients and reducing the serious impacts of CAD.

Methods

This clinical-based cross-sectional study comprised 100 consecutive patients in India from 2014 to 2016. In this research, PAD patients were screened for CAD by treadmill stress test and cardiac colour Doppler examination. In addition, this study performed coronary angiography followed by peripheral angiography for patients who could not perform the treadmill test.

Results

With the statistical results, the study observed a high prevalence of CAD in PAD patients that can be detected only with angiography. Further, 30.93% of asymptomatic CAD prevalence was observed in PAD patients. The study strengthens the need for coronary angiography in all symptomatic lower limb PAD cases to detect early CAD, particularly in patients with diabetes and dyslipidemia.

Conclusion

There exists a strong correlation between PAD and CAD. Hence, precise diagnosis followed by supervision of PAD patients is significant for avoiding local progression of cardiovascular risk.

目的与健康人相比,外周动脉疾病(PAD)患者发生亚临床冠状动脉疾病(CAD)和心血管事件的风险普遍很高。确定PAD患者CAD的相关性,从而提高PAD患者的生存期,减少CAD的严重影响。方法本临床横断面研究纳入2014 - 2016年印度连续100例患者。在本研究中,PAD患者通过跑步机负荷试验和心脏彩色多普勒检查筛查CAD。此外,本研究对不能进行跑步机试验的患者进行冠状动脉造影和外周血管造影。结果通过统计结果,本研究观察到PAD患者中CAD的高患病率,而这只能通过血管造影来检测。此外,无症状CAD患病率在PAD患者中占30.93%。该研究加强了对所有有症状的下肢PAD病例进行冠状动脉造影以发现早期CAD的必要性,特别是糖尿病和血脂异常患者。结论PAD与冠心病有较强的相关性。因此,对PAD患者进行精确的诊断和监护对于避免局部心血管危险的进展具有重要意义。
{"title":"A cross-sectional study on coronary artery disease diagnosis in patients with peripheral artery disease","authors":"Jai Bharat Bhalke ,&nbsp;Shirish Hiremath ,&nbsp;C.N. Makhale","doi":"10.1016/j.jimed.2022.09.005","DOIUrl":"10.1016/j.jimed.2022.09.005","url":null,"abstract":"<div><h3>Purpose</h3><p>Compared with healthy individuals, patients with peripheral artery disease (PAD) generally have a very high risk of subclinical Coronary artery disease (CAD) and cardiovascular events. To determine the correlation between CAD in PAD patients, thereby promoting the lifetime of PAD patients and reducing the serious impacts of CAD.</p></div><div><h3>Methods</h3><p>This clinical-based cross-sectional study comprised 100 consecutive patients in India from 2014 to 2016. In this research, PAD patients were screened for CAD by treadmill stress test and cardiac colour Doppler examination. In addition, this study performed coronary angiography followed by peripheral angiography for patients who could not perform the treadmill test.</p></div><div><h3>Results</h3><p>With the statistical results, the study observed a high prevalence of CAD in PAD patients that can be detected only with angiography. Further, 30.93% of asymptomatic CAD prevalence was observed in PAD patients. The study strengthens the need for coronary angiography in all symptomatic lower limb PAD cases to detect early CAD, particularly in patients with diabetes and dyslipidemia.</p></div><div><h3>Conclusion</h3><p>There exists a strong correlation between PAD and CAD. Hence, precise diagnosis followed by supervision of PAD patients is significant for avoiding local progression of cardiovascular risk.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/12/f3/main.PMC9751211.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10766457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thermal ablation for papillary thyroid microcarcinoma: Some clarity amid controversies 热消融治疗甲状腺乳头状微癌:争议中的一些澄清
Q3 Medicine Pub Date : 2022-11-01 DOI: 10.1016/j.jimed.2022.07.002
Wenwen Yue, Shurong Wang, Huixiong Xu

The increasing incidence of papillary thyroid microcarcinoma (PTMC) has become a global challenge. Because of its indolent nature, active surveillance (AS) has been proposed as a treatment option in selected PTMC patients to prevent surgery-related complications. However, only a few patients with PTMC receive the AS approach because of the serious psychological burden following the “cancer” diagnosis and the uncertainty of the timing for metastatic dissemination. Ultrasound (US)-guided thermal ablation can bridge the gap in the treatment options of PTMC patients who wish for a minimally invasive management approach. However, it has acquired only marginal attention from the thyroid guideline societies because of concerns regarding incomplete elimination. The recently published guidelines from the European Thyroid Association-Cardiovascular and Interventional Radiological Society of Europe and the American Head Neck Society Endocrine Section -initiated global consensus provide the most definitive evidence and essential foundational experience to address the long-term controversy over US-guided thermal ablation for low-risk PTMC patient management and facilitate the responsible global dissemination of minimally invasive strategies.

甲状腺乳头状微癌(PTMC)发病率的上升已成为一个全球性的挑战。由于其惰性性质,主动监测(AS)已被建议作为一种治疗选择,在选定的PTMC患者,以防止手术相关并发症。然而,由于“癌症”诊断后严重的心理负担和转移传播时机的不确定性,只有少数PTMC患者接受AS方法。超声(US)引导的热消融可以弥补PTMC患者希望采用微创治疗方法的治疗选择的差距。然而,由于担心不完全消除,它只获得了甲状腺指南协会的边缘关注。最近由欧洲甲状腺协会-欧洲心血管和介入放射学会和美国头颈学会内分泌科发布的指南,发起了全球共识,为解决美国引导的低风险PTMC患者热消融治疗的长期争议提供了最明确的证据和必要的基础经验,并促进了负责的微创策略的全球传播。
{"title":"Thermal ablation for papillary thyroid microcarcinoma: Some clarity amid controversies","authors":"Wenwen Yue,&nbsp;Shurong Wang,&nbsp;Huixiong Xu","doi":"10.1016/j.jimed.2022.07.002","DOIUrl":"10.1016/j.jimed.2022.07.002","url":null,"abstract":"<div><p>The increasing incidence of papillary thyroid microcarcinoma (PTMC) has become a global challenge. Because of its indolent nature, active surveillance (AS) has been proposed as a treatment option in selected PTMC patients to prevent surgery-related complications. However, only a few patients with PTMC receive the AS approach because of the serious psychological burden following the “cancer” diagnosis and the uncertainty of the timing for metastatic dissemination. Ultrasound (US)-guided thermal ablation can bridge the gap in the treatment options of PTMC patients who wish for a minimally invasive management approach. However, it has acquired only marginal attention from the thyroid guideline societies because of concerns regarding incomplete elimination. The recently published guidelines from the European Thyroid Association-Cardiovascular and Interventional Radiological Society of Europe and the American Head Neck Society Endocrine Section -initiated global consensus provide the most definitive evidence and essential foundational experience to address the long-term controversy over US-guided thermal ablation for low-risk PTMC patient management and facilitate the responsible global dissemination of minimally invasive strategies.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f4/ec/main.PMC9751214.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10460773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microwave ablation of colorectal liver metastases adjacent to the cardiophrenic angle: Parallel versus non-parallel placement of the antenna relative to the diaphragm 贲门角附近结直肠癌肝转移灶的微波消融:相对于膈膜平行与非平行放置天线
Q3 Medicine Pub Date : 2022-08-01 DOI: 10.1016/j.jimed.2022.04.003
Rui Cui , Xiaowen Liu , Yao Chen, Si Qin, Yimin Wang, Guangjian Liu

Purpose

Microwave ablation (MWA) is difficult to perform in colorectal liver metastases (CRLMs) adjacent to the cardiophrenic angle. Therefore, a modified approach involving antenna array placement parallel to the diaphragm was initially attempted. Its safety and efficacy were compared with those involving non-parallel placement.

Methods

Sixty-three patients with CRLMs adjacent to the cardiophrenic angle (lesions within 10 ​mm of the diaphragm) who underwent MWA were included in the study. All patients were further classified into parallel and non-parallel groups according to the method of antenna placement. The distance between the lesion and diaphragmatic surface before MWA, complications, and local tumor progression (LTP) at the last imaging follow-up were recorded. LTPs in the two groups were compared using the log-rank test. Prognostic factors for LTP were assessed using the Cox proportional hazards regression model.

Results

Thirty and 33 lesions were ablated using parallel and non-parallel antenna placement, respectively. During the mean follow-up duration of 19.7 ​± ​8.2 months, the LTP rate in the parallel and non-parallel placement groups were 3.3% (1/30) and 24.2% (8/33), respectively. The log-rank test showed that parallel antenna placement was associated with delayed LTP (p ​= ​0.018). Multivariate Cox regression analysis showed that parallel antenna placement was an independent predictor of delayed LTP after adjusting for possible risk factors, including age, sex, tumor size, and KRAS mutation (hazard ratio, 0.1; 95% confidence interval, 0.00, 0.80; p ​= ​0.034).

Conclusion

The placement of the antenna parallel to the diaphragm is an alternative and effective method for MWA of CRLMs near the cardiophrenic angle and can contribute to the reduction of the LTP rate.

目的:微波消融术(MWA)治疗贲门角附近结直肠肝转移瘤(crlm)较为困难。因此,一种改进的方法涉及天线阵列放置平行于膜片最初被尝试。比较非平行放置组的安全性和有效性。方法对63例心绞痛角附近CRLMs(膈10 mm内病变)行MWA的患者进行研究。根据天线放置方式将所有患者进一步分为平行组和非平行组。记录MWA前病变与膈面之间的距离、并发症和最后一次影像学随访时局部肿瘤进展(LTP)。两组ltp比较采用log-rank检验。使用Cox比例风险回归模型评估LTP的预后因素。结果采用平行天线和非平行天线分别消融病变30例和33例。在平均随访19.7±8.2个月期间,平行放置组和非平行放置组的LTP率分别为3.3%(1/30)和24.2%(8/33)。log-rank检验显示平行天线放置与延迟LTP相关(p = 0.018)。多因素Cox回归分析显示,在调整了可能的危险因素(包括年龄、性别、肿瘤大小和KRAS突变)后,平行天线放置是延迟LTP的独立预测因子(风险比,0.1;95%置信区间0.00,0.80;p = 0.034)。结论平行于膜片放置天线是治疗心绞痛角附近CRLMs的另一种有效方法,可降低LTP率。
{"title":"Microwave ablation of colorectal liver metastases adjacent to the cardiophrenic angle: Parallel versus non-parallel placement of the antenna relative to the diaphragm","authors":"Rui Cui ,&nbsp;Xiaowen Liu ,&nbsp;Yao Chen,&nbsp;Si Qin,&nbsp;Yimin Wang,&nbsp;Guangjian Liu","doi":"10.1016/j.jimed.2022.04.003","DOIUrl":"10.1016/j.jimed.2022.04.003","url":null,"abstract":"<div><h3>Purpose</h3><p>Microwave ablation (MWA) is difficult to perform in colorectal liver metastases (CRLMs) adjacent to the cardiophrenic angle. Therefore, a modified approach involving antenna array placement parallel to the diaphragm was initially attempted. Its safety and efficacy were compared with those involving non-parallel placement.</p></div><div><h3>Methods</h3><p>Sixty-three patients with CRLMs adjacent to the cardiophrenic angle (lesions within 10 ​mm of the diaphragm) who underwent MWA were included in the study. All patients were further classified into parallel and non-parallel groups according to the method of antenna placement. The distance between the lesion and diaphragmatic surface before MWA, complications, and local tumor progression (LTP) at the last imaging follow-up were recorded. LTPs in the two groups were compared using the log-rank test. Prognostic factors for LTP were assessed using the Cox proportional hazards regression model.</p></div><div><h3>Results</h3><p>Thirty and 33 lesions were ablated using parallel and non-parallel antenna placement, respectively. During the mean follow-up duration of 19.7 ​± ​8.2 months, the LTP rate in the parallel and non-parallel placement groups were 3.3% (1/30) and 24.2% (8/33), respectively. The log-rank test showed that parallel antenna placement was associated with delayed LTP (<em>p</em> ​= ​0.018). Multivariate Cox regression analysis showed that parallel antenna placement was an independent predictor of delayed LTP after adjusting for possible risk factors, including age, sex, tumor size, and KRAS mutation (hazard ratio, 0.1; 95% confidence interval, 0.00, 0.80; <em>p</em> ​= ​0.034).</p></div><div><h3>Conclusion</h3><p>The placement of the antenna parallel to the diaphragm is an alternative and effective method for MWA of CRLMs near the cardiophrenic angle and can contribute to the reduction of the LTP rate.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2f/f9/main.PMC9617147.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40657950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of contrast-enhanced ultrasound-guided percutaneous core needle biopsy in anterior mediastinal masses 超声造影引导下经皮穿刺前纵隔肿块活检的疗效
Q3 Medicine Pub Date : 2022-08-01 DOI: 10.1016/j.jimed.2022.04.006
Peili Fan , Jiaying Cao , Yunjie Jin , Hong Han , Wenping Wang , Huixiong Xu , Zhengbiao Ji

Objective

To evaluate the efficacy and safety of percutaneous core needle biopsy (PCNB) using ultrasound (US)-guided and contrast-enhanced ultrasound (CEUS)-guided procedures for anterior mediastinal masses (AMMs).

Methods

In total, 284 consecutive patients (166 men, 118 women; mean age, 43.0 ​± ​18.4 years) who underwent PCNB for AMMs were enrolled. Patients were divided into the US-guided group (n ​= ​133) and the CEUS-guided group (n ​= ​151). PCNB was performed using a core needle (16-gauge or 18-gauge). Internal necrosis, diagnostic yield, and diagnostic accuracy were compared between the two groups.

Results

The predominant final diagnosis of the cases in this study was thymoma (29.7%), lymphoma (20.5%), thymic carcinoma (13.3%), and germ cell tumour (13.3%), respectively. There was no significant difference in patient age, sex, number of percutaneous biopsies, or display rate of internal necrosis on conventional US between the two groups. The rate of internal necrosis of the lesions was significantly higher after contrast agent injection (72.2% vs. 41.7%; P ​< ​0.001). The CEUS-guided group had a higher diagnostic yield than the US-guided group (100% vs. 89.5%, P ​< ​0.001). There was no significant difference between the diagnostic accuracy of the CEUS-guided and US-guided groups (97.3% vs. 97.4%; P ​= ​1.000). None of the patients experienced adverse reactions or complications after US-guided or CEUS-guided PCNB.

Conclusions

CEUS-guided PCNB can improve the diagnostic yield by optimizing the biopsy procedure.

目的评价超声(US)引导和超声增强(CEUS)引导下经皮穿刺穿刺活检(PCNB)治疗前纵隔肿块(AMMs)的有效性和安全性。方法共284例患者(男性166例,女性118例;平均年龄(43.0±18.4岁)。患者分为us引导组(133例)和超声造影引导组(151例)。PCNB采用芯针(16号或18号)。比较两组间的内坏死、诊断率和诊断准确性。结果本组病例的最终诊断以胸腺瘤(29.7%)、淋巴瘤(20.5%)、胸腺癌(13.3%)和生殖细胞瘤(13.3%)为主。两组患者在年龄、性别、经皮活检次数、常规超声检查内坏死显示率等方面均无显著差异。注射造影剂后病变内坏死率明显增高(72.2% vs. 41.7%;P & lt;0.001)。超声造影引导组的诊断率高于超声引导组(100% vs. 89.5%, P <0.001)。超声造影引导组和超声引导组的诊断准确率无显著差异(97.3% vs 97.4%;p = 1.000)。us引导或超声造影引导下的PCNB均未发生不良反应或并发症。结论超声引导下PCNB可通过优化活检方法提高诊断准确率。
{"title":"Efficacy of contrast-enhanced ultrasound-guided percutaneous core needle biopsy in anterior mediastinal masses","authors":"Peili Fan ,&nbsp;Jiaying Cao ,&nbsp;Yunjie Jin ,&nbsp;Hong Han ,&nbsp;Wenping Wang ,&nbsp;Huixiong Xu ,&nbsp;Zhengbiao Ji","doi":"10.1016/j.jimed.2022.04.006","DOIUrl":"10.1016/j.jimed.2022.04.006","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the efficacy and safety of percutaneous core needle biopsy (PCNB) using ultrasound (US)-guided and contrast-enhanced ultrasound (CEUS)-guided procedures for anterior mediastinal masses (AMMs).</p></div><div><h3>Methods</h3><p>In total, 284 consecutive patients (166 men, 118 women; mean age, 43.0 ​± ​18.4 years) who underwent PCNB for AMMs were enrolled. Patients were divided into the US-guided group (n ​= ​133) and the CEUS-guided group (n ​= ​151). PCNB was performed using a core needle (16-gauge or 18-gauge). Internal necrosis, diagnostic yield, and diagnostic accuracy were compared between the two groups.</p></div><div><h3>Results</h3><p>The predominant final diagnosis of the cases in this study was thymoma (29.7%), lymphoma (20.5%), thymic carcinoma (13.3%), and germ cell tumour (13.3%), respectively. There was no significant difference in patient age, sex, number of percutaneous biopsies, or display rate of internal necrosis on conventional US between the two groups. The rate of internal necrosis of the lesions was significantly higher after contrast agent injection (72.2% vs. 41.7%; <em>P</em> ​&lt; ​0.001). The CEUS-guided group had a higher diagnostic yield than the US-guided group (100% vs. 89.5%, <em>P</em> ​&lt; ​0.001). There was no significant difference between the diagnostic accuracy of the CEUS-guided and US-guided groups (97.3% vs. 97.4%; <em>P</em> ​= ​1.000). None of the patients experienced adverse reactions or complications after US-guided or CEUS-guided PCNB.</p></div><div><h3>Conclusions</h3><p>CEUS-guided PCNB can improve the diagnostic yield by optimizing the biopsy procedure.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a3/6b/main.PMC9617154.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40659524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Ultrasound-guided microwave ablation for symptomatic adenomyosis: More areas of concern for more uniform and promising outcomes 超声引导微波消融治疗症状性bbb:更多领域关注更统一和有希望的结果
Q3 Medicine Pub Date : 2022-08-01 DOI: 10.1016/j.jimed.2022.06.001
Huili Zhang, Songyuan Yu, Huixiong Xu

Adenomyosis is a common gynecological disease in reproductive women, which causes serious dysmenorrhea, menorrhagia, anemia, and infertility, and has a serious impact on the physical and mental health of women. Considering that the efficacy of the traditional medication and surgical treatment is not ideal, an increasing number of patients are searching for more effective and less invasive therapies. Ultrasound (US)-guided microwave ablation (MWA) has emerged as a new effective and minimally invasive alternative treatment for symptomatic adenomyosis, and it is widely being used in clinical settings. Several studies have proven that it is an efficient and safe treatment modality for symptomatic adenomyosis, but a significant variance in clinical outcomes reported in previous studies was also observed. Herein, we have analyzed the potential causes of this problem from the aspects of the diagnosis of adenomyosis, symptom evaluation before ablation, steps of US-guided ablation treatment, and outcome evaluation after ablation. Simultaneously, the clinical problems existing in the ablation treatment of adenomyosis are discussed, and the directions of future research are pointed out.

子宫腺肌症是生殖女性常见的妇科疾病,可引起严重的痛经、月经过多、贫血、不孕症,严重影响女性的身心健康。考虑到传统药物和手术治疗的效果并不理想,越来越多的患者开始寻求更有效、更少侵入性的治疗方法。超声(US)引导下的微波消融术(MWA)作为一种新的、有效的、微创的治疗症状性脑卒中的替代方法,在临床中得到了广泛的应用。一些研究已经证明它是一种有效和安全的治疗症状性bbb的方式,但也观察到以往研究报告的临床结果存在显着差异。本文从子宫腺肌症的诊断、消融前的症状评价、美国引导下的消融步骤、消融后的预后评价等方面分析了该问题的潜在原因。同时讨论了子宫腺肌症消融治疗中存在的临床问题,并指出了今后的研究方向。
{"title":"Ultrasound-guided microwave ablation for symptomatic adenomyosis: More areas of concern for more uniform and promising outcomes","authors":"Huili Zhang,&nbsp;Songyuan Yu,&nbsp;Huixiong Xu","doi":"10.1016/j.jimed.2022.06.001","DOIUrl":"10.1016/j.jimed.2022.06.001","url":null,"abstract":"<div><p>Adenomyosis is a common gynecological disease in reproductive women, which causes serious dysmenorrhea, menorrhagia, anemia, and infertility, and has a serious impact on the physical and mental health of women. Considering that the efficacy of the traditional medication and surgical treatment is not ideal, an increasing number of patients are searching for more effective and less invasive therapies. Ultrasound (US)-guided microwave ablation (MWA) has emerged as a new effective and minimally invasive alternative treatment for symptomatic adenomyosis, and it is widely being used in clinical settings. Several studies have proven that it is an efficient and safe treatment modality for symptomatic adenomyosis, but a significant variance in clinical outcomes reported in previous studies was also observed. Herein, we have analyzed the potential causes of this problem from the aspects of the diagnosis of adenomyosis, symptom evaluation before ablation, steps of US-guided ablation treatment, and outcome evaluation after ablation. Simultaneously, the clinical problems existing in the ablation treatment of adenomyosis are discussed, and the directions of future research are pointed out.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/0f/main.PMC9617158.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40657953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Uterine artery embolization combined with ultrasound-guided dilation and curettage for the treatment of cesarean scar pregnancy: Efficacy and 5–8-year follow-up study 子宫动脉栓塞联合超声引导下扩张刮除术治疗剖宫产瘢痕妊娠的疗效及5 - 8年随访研究
Q3 Medicine Pub Date : 2022-08-01 DOI: 10.1016/j.jimed.2022.03.006
Zhuxin Gu , Pengfei Jia , Ziyang Gao , Weiwei Gu , Hui Zhao , Suming Zhao

Objective

To evaluate the efficacy and safety of uterine artery embolization (UAE) combined with dilation and curettage (D&C) using ultrasound as a treatment for cesarean scar pregnancy (CSP) and assess its effect on ovarian and reproductive function.

Methods

A total of 54 patients with uterine CSP between January 2011 and December 2015 were included in this retrospective study. The patients were treated with UAE combined with D&C using ultrasound for the treatment of CSP and followed up for 5–8 years. Their medical records, medical histories, clinical manifestations, treatment courses, and treatment results were analyzed.

Results

The 54 patients were initially treated without severe complications. β-Human chorionic gonadotropin (β-hCG) normalization took 36.11 ​± ​10.73 days (range, 25–84 days), length of hospitalization was 6.6 ​± ​1.5 days (range, 4–10 days), and total blood loss was 18.48 ​± ​8.41 ​mL (range, 5–33 ​mL). All patients resumed normal menstruation after 33.48 ​± ​8.71 days (range, 26–70 days). At the 5–8-year follow-up after UAE combined with D&C by ultrasound for the treatment of uterine CSP, the menstrual volume in 32 (59.3%) patients decreased versus before the operation. Compared with pretreatment, the menstrual cycle was prolonged in two (3.7%) cases, shortened in 10 (18.5%) cases, irregular in one (1.9%) case, and unchanged in 39 (72.2%) cases. Three patients conceived naturally and successfully gave birth to healthy children. Seven (12.96%) patients with accidental natural pregnancies chose induced abortion with no significant change in their sex lives.

Conclusion

UAE combined with D&C using ultrasound for the treatment of uterine CSP is safe and effective and may not affect the fertility of patients aged <40 years. However, menstrual volume may be reduced in some patients.

目的评价超声子宫动脉栓塞术(UAE)联合子宫扩张刮除术(D&C)治疗剖宫产瘢痕妊娠(CSP)的疗效和安全性,并评价其对卵巢和生殖功能的影响。方法回顾性分析2011年1月~ 2015年12月子宫CSP患者54例。采用超声联合UAE联合D&C治疗CSP,随访5-8年。分析患者的病历、病史、临床表现、疗程及治疗结果。结果54例患者初治无严重并发症。β-人绒毛膜促性腺激素(β-hCG)正常化需要36.11±10.73天(范围,25-84天),住院时间6.6±1.5天(范围,4-10天),总失血量18.48±8.41 mL(范围,5-33 mL)。术后33.48±8.71 d(范围:26 ~ 70 d)月经恢复正常。UAE联合超声D&C治疗子宫CSP后5 ~ 8年随访,32例(59.3%)患者月经量较术前下降。与前处理相比,月经周期延长2例(3.7%),缩短10例(18.5%),不规则1例(1.9%),不变39例(72.2%)。三名患者自然受孕并成功生下健康的孩子。7例(12.96%)意外自然妊娠患者选择人工流产,性生活无明显改变。结论uae联合超声D&C治疗子宫CSP安全有效,不影响40岁高龄患者的生育能力。然而,一些患者的月经量可能会减少。
{"title":"Uterine artery embolization combined with ultrasound-guided dilation and curettage for the treatment of cesarean scar pregnancy: Efficacy and 5–8-year follow-up study","authors":"Zhuxin Gu ,&nbsp;Pengfei Jia ,&nbsp;Ziyang Gao ,&nbsp;Weiwei Gu ,&nbsp;Hui Zhao ,&nbsp;Suming Zhao","doi":"10.1016/j.jimed.2022.03.006","DOIUrl":"10.1016/j.jimed.2022.03.006","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the efficacy and safety of uterine artery embolization (UAE) combined with dilation and curettage (D&amp;C) using ultrasound as a treatment for cesarean scar pregnancy (CSP) and assess its effect on ovarian and reproductive function.</p></div><div><h3>Methods</h3><p>A total of 54 patients with uterine CSP between January 2011 and December 2015 were included in this retrospective study. The patients were treated with UAE combined with D&amp;C using ultrasound for the treatment of CSP and followed up for 5–8 years. Their medical records, medical histories, clinical manifestations, treatment courses, and treatment results were analyzed.</p></div><div><h3>Results</h3><p>The 54 patients were initially treated without severe complications. β-Human chorionic gonadotropin (β-hCG) normalization took 36.11 ​± ​10.73 days (range, 25–84 days), length of hospitalization was 6.6 ​± ​1.5 days (range, 4–10 days), and total blood loss was 18.48 ​± ​8.41 ​mL (range, 5–33 ​mL). All patients resumed normal menstruation after 33.48 ​± ​8.71 days (range, 26–70 days). At the 5–8-year follow-up after UAE combined with D&amp;C by ultrasound for the treatment of uterine CSP, the menstrual volume in 32 (59.3%) patients decreased versus before the operation. Compared with pretreatment, the menstrual cycle was prolonged in two (3.7%) cases, shortened in 10 (18.5%) cases, irregular in one (1.9%) case, and unchanged in 39 (72.2%) cases. Three patients conceived naturally and successfully gave birth to healthy children. Seven (12.96%) patients with accidental natural pregnancies chose induced abortion with no significant change in their sex lives.</p></div><div><h3>Conclusion</h3><p>UAE combined with D&amp;C using ultrasound for the treatment of uterine CSP is safe and effective and may not affect the fertility of patients aged &lt;40 years. However, menstrual volume may be reduced in some patients.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5f/6d/main.PMC9617151.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40657952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Balloon-occluded retrograde transvenous obliteration with lauromacrogol sclerosant foam for gastric varices 胃底静脉曲张的球囊闭塞逆行经静脉闭塞与聚桂醇硬化泡沫
Q3 Medicine Pub Date : 2022-08-01 DOI: 10.1016/j.jimed.2022.06.002
Zhiyang Wu , Wei Wu , Cheng Tao , Qin Liu , Wenchang Li , Qinbing Wang , Wei Huang , Junwei Gu , Xiaoyan Fei , Zhongmin Wang , Xiaoyi Ding

Objectives

To evaluate the safety and efficacy of balloon-occluded retrograde transvenous obliteration (BRTO) using lauromacrogol sclerosant foam for gastric varices (GVs) with gastrorenal venous shunts.

Methods

Data of GV patients treated with BRTO using lauromacrogol sclerosant foam in 2016–2020 were retrospectively analyzed along with procedural success rate, complications, and follow-up efficacy.

Results

A total of 31 patients were treated with BRTO. The sclerosant foam was prepared by mixing iodinated oil, lauromacrogol, and air at a 1:2:3 ratio. The BRTO procedure was successfully completed in 93.5% of patients. One patient was allergic to the lauromacrogol injection. A mild postoperative fever occurred in three patients. One patient experienced grand mal seizures after the procedure. There was no significant difference in the median Child-Turcotte-Pugh scores before versus after BRTO. Complete GV resolution was observed in 93.1% of patients. One patient underwent endoscopic treatment for the development of high-risk esophageal varices. Another patient underwent transjugular intrahepatic portosystemic shunt placement for the aggravation of ascites.

Conclusions

Lauromacrogol sclerosant foam is safe and effective in patients undergoing BRTO for GV.

目的评价聚桂醇硬化剂泡沫球囊闭塞逆行经静脉闭塞术(BRTO)治疗胃静脉曲张合并胃肾静脉分流术的安全性和有效性。方法回顾性分析2016-2020年使用聚桂醇硬化剂泡沫进行BRTO治疗的GV患者的手术成功率、并发症及随访疗效。结果31例患者接受BRTO治疗。将碘化油、聚月桂醇和空气按1:2:3的比例混合制备硬化剂泡沫。93.5%的患者成功完成了BRTO手术。一名患者对聚月桂醇注射液过敏。3例患者术后出现轻度发热。一名患者在手术后出现了严重癫痫发作。BRTO前后child - turcote - pugh评分中位数无显著差异。93.1%的患者GV完全消退。一名患者因发生高危食管静脉曲张而接受内镜治疗。另一名患者因腹水加重而行经颈静脉肝内门静脉分流术。结论聚硫醇硬化剂泡沫治疗GV行BRTO手术安全有效。
{"title":"Balloon-occluded retrograde transvenous obliteration with lauromacrogol sclerosant foam for gastric varices","authors":"Zhiyang Wu ,&nbsp;Wei Wu ,&nbsp;Cheng Tao ,&nbsp;Qin Liu ,&nbsp;Wenchang Li ,&nbsp;Qinbing Wang ,&nbsp;Wei Huang ,&nbsp;Junwei Gu ,&nbsp;Xiaoyan Fei ,&nbsp;Zhongmin Wang ,&nbsp;Xiaoyi Ding","doi":"10.1016/j.jimed.2022.06.002","DOIUrl":"10.1016/j.jimed.2022.06.002","url":null,"abstract":"<div><h3>Objectives</h3><p>To evaluate the safety and efficacy of balloon-occluded retrograde transvenous obliteration (BRTO) using lauromacrogol sclerosant foam for gastric varices (GVs) with gastrorenal venous shunts.</p></div><div><h3>Methods</h3><p>Data of GV patients treated with BRTO using lauromacrogol sclerosant foam in 2016–2020 were retrospectively analyzed along with procedural success rate, complications, and follow-up efficacy.</p></div><div><h3>Results</h3><p>A total of 31 patients were treated with BRTO. The sclerosant foam was prepared by mixing iodinated oil, lauromacrogol, and air at a 1:2:3 ratio. The BRTO procedure was successfully completed in 93.5% of patients. One patient was allergic to the lauromacrogol injection. A mild postoperative fever occurred in three patients. One patient experienced grand mal seizures after the procedure. There was no significant difference in the median Child-Turcotte-Pugh scores before versus after BRTO. Complete GV resolution was observed in 93.1% of patients. One patient underwent endoscopic treatment for the development of high-risk esophageal varices. Another patient underwent transjugular intrahepatic portosystemic shunt placement for the aggravation of ascites.</p></div><div><h3>Conclusions</h3><p>Lauromacrogol sclerosant foam is safe and effective in patients undergoing BRTO for GV.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cf/76/main.PMC9617148.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40659526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Recent advances of multimoda ultrasound in image-guided prostate-targeted biopsy 多模态超声在图像引导前列腺靶向活检中的最新进展
Q3 Medicine Pub Date : 2022-08-01 DOI: 10.1016/j.jimed.2022.04.005
Yunyun Liu, Lihua Xiang, Guang Xu, Yifeng Zhang, Huixiong Xu

Prostate-targeted biopsy is usually the preferred method over systematic biopsy because it can effectively detect prostate cancer using only a few puncture cores with fewer complications. With the development of ultrasound, it has gained multimodal technological upgrades, such as the emergence of contrast-enhanced ultrasound, ultrasound elastography, and three-dimensional ultrasonography. Moreover, multimodal ultrasound has played an increasingly significant role in prostate-targeted biopsies.

前列腺靶向活检通常是优于系统活检的方法,因为它可以有效地检测前列腺癌,只需几个穿刺孔,并发症较少。随着超声技术的发展,超声技术得到了多模态的技术升级,如增强超声、超声弹性成像、三维超声等技术的出现。此外,多模态超声在前列腺靶向活检中发挥着越来越重要的作用。
{"title":"Recent advances of multimoda ultrasound in image-guided prostate-targeted biopsy","authors":"Yunyun Liu,&nbsp;Lihua Xiang,&nbsp;Guang Xu,&nbsp;Yifeng Zhang,&nbsp;Huixiong Xu","doi":"10.1016/j.jimed.2022.04.005","DOIUrl":"10.1016/j.jimed.2022.04.005","url":null,"abstract":"<div><p>Prostate-targeted biopsy is usually the preferred method over systematic biopsy because it can effectively detect prostate cancer using only a few puncture cores with fewer complications. With the development of ultrasound, it has gained multimodal technological upgrades, such as the emergence of contrast-enhanced ultrasound, ultrasound elastography, and three-dimensional ultrasonography. Moreover, multimodal ultrasound has played an increasingly significant role in prostate-targeted biopsies.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7e/9a/main.PMC9617149.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40659525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A canine model of aortic arch aneurysm created with autologous pericardium 犬自体心包制备主动脉弓动脉瘤模型
Q3 Medicine Pub Date : 2022-08-01 DOI: 10.1016/j.jimed.2022.06.005
Weixiao Li , Jun Li , Qiang li , Mingzhe Cui , Rutao Xu , Shuiting Zhai , Cheshire Nick , Tianxiao Li , Jiangbo Chen , Wenli Zhao

Background

To establish a canine model of aortic arch aneurysm that is suitable for research on new devices and techniques applied to the aortic arch.

Materials and methods

Fifteen mongrel dogs underwent surgery. The autologous pericardial patch was sewn on the aortotomy site in the anterior wall of the aortic arch. The animals were followed up for 3 months postoperatively. Computed tomography angiography was used to visualize and measure the aneurysm model. Hematoxylin and eosin staining was used to observe the histological characteristics of the aneurysm model. Changes in aneurysm diameter over time were analyzed using analysis of variance.

Results

One dog died of hemorrhage during surgery. Fourteen dogs survived the surgical procedure. Two of them died on the first postoperative day because of ruptures at the suturing margin. The diameter of the aneurysm model was twice as large as that of the aortic arch. There was no significant change in the maximum diameter of the aneurysm model during the follow-up period.

Conclusions

We established a controllable and stable aortic arch aneurysm model created with an autologous pericardium patch. The aneurysm model can be used to research endoleaks after thoracic endovascular aortic repair and new endovascular techniques can be applied to the aortic arch.

背景:建立犬主动脉弓动脉瘤模型,为主动脉弓治疗新装置和新技术的研究提供依据。材料与方法15只杂种犬接受手术治疗。将自体心包补片缝合于主动脉弓前壁主动脉切开处。术后随访3个月。使用计算机断层血管造影对动脉瘤模型进行可视化和测量。采用苏木精和伊红染色观察动脉瘤模型的组织学特征。采用方差分析分析动脉瘤直径随时间的变化。结果1只狗手术中出血死亡。14只狗在手术过程中幸存下来。其中2例因缝合缘破裂于术后第一天死亡。动脉瘤模型的直径是主动脉弓直径的两倍。动脉瘤模型的最大直径在随访期间无明显变化。结论采用自体心包贴片建立了可控、稳定的主动脉弓动脉瘤模型。该动脉瘤模型可用于研究胸主动脉腔内修复后的腔内渗漏,并可将新的腔内技术应用于主动脉弓。
{"title":"A canine model of aortic arch aneurysm created with autologous pericardium","authors":"Weixiao Li ,&nbsp;Jun Li ,&nbsp;Qiang li ,&nbsp;Mingzhe Cui ,&nbsp;Rutao Xu ,&nbsp;Shuiting Zhai ,&nbsp;Cheshire Nick ,&nbsp;Tianxiao Li ,&nbsp;Jiangbo Chen ,&nbsp;Wenli Zhao","doi":"10.1016/j.jimed.2022.06.005","DOIUrl":"10.1016/j.jimed.2022.06.005","url":null,"abstract":"<div><h3>Background</h3><p>To establish a canine model of aortic arch aneurysm that is suitable for research on new devices and techniques applied to the aortic arch.</p></div><div><h3>Materials and methods</h3><p>Fifteen mongrel dogs underwent surgery. The autologous pericardial patch was sewn on the aortotomy site in the anterior wall of the aortic arch. The animals were followed up for 3 months postoperatively. Computed tomography angiography was used to visualize and measure the aneurysm model. Hematoxylin and eosin staining was used to observe the histological characteristics of the aneurysm model. Changes in aneurysm diameter over time were analyzed using analysis of variance.</p></div><div><h3>Results</h3><p>One dog died of hemorrhage during surgery. Fourteen dogs survived the surgical procedure. Two of them died on the first postoperative day because of ruptures at the suturing margin. The diameter of the aneurysm model was twice as large as that of the aortic arch. There was no significant change in the maximum diameter of the aneurysm model during the follow-up period.</p></div><div><h3>Conclusions</h3><p>We established a controllable and stable aortic arch aneurysm model created with an autologous pericardium patch. The aneurysm model can be used to research endoleaks after thoracic endovascular aortic repair and new endovascular techniques can be applied to the aortic arch.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/bd/main.PMC9617150.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40657948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis of hepatic inflammatory pseudotumor by fine-needle biopsy 肝炎性假瘤的细针活检诊断
Q3 Medicine Pub Date : 2022-08-01 DOI: 10.1016/j.jimed.2022.04.002
Min Lin, Lan Cao, Jianwei Wang, Jianhua Zhou

Hepatic inflammatory pseudotumor (IPT) is a benign lesion characterized by chronic infiltration of inflammatory cells and fibrosis that clinically, radiologically, and pathologically mimics malignancy. However, the epidemiology of IPTs remains unclear. IPTs are often misdiagnosed as malignant lesions because of the lack of characteristic features. We present the case of a 32-year-old man that was misdiagnosed as intrahepatic cholangiocarcinoma by CECT, CEMRI, and CEUS, which was finally confirmed as IPT by fine-needle liver biopsy. In this report, the key factor in the diagnosis of liver inflammatory masses was the presence of hepatic perfusion disorder.

肝炎性假瘤(IPT)是一种以慢性炎性细胞浸润和纤维化为特征的良性病变,在临床、放射学和病理学上与恶性肿瘤相似。然而,ipt的流行病学仍不清楚。由于缺乏特征性表现,常被误诊为恶性病变。我们报告一例32岁男性患者,经CECT、CEMRI和CEUS误诊为肝内胆管癌,最终经细针肝活检证实为肝内胆管癌。在本报告中,诊断肝脏炎性肿块的关键因素是肝脏灌注障碍的存在。
{"title":"Diagnosis of hepatic inflammatory pseudotumor by fine-needle biopsy","authors":"Min Lin,&nbsp;Lan Cao,&nbsp;Jianwei Wang,&nbsp;Jianhua Zhou","doi":"10.1016/j.jimed.2022.04.002","DOIUrl":"10.1016/j.jimed.2022.04.002","url":null,"abstract":"<div><p>Hepatic inflammatory pseudotumor (IPT) is a benign lesion characterized by chronic infiltration of inflammatory cells and fibrosis that clinically, radiologically, and pathologically mimics malignancy. However, the epidemiology of IPTs remains unclear. IPTs are often misdiagnosed as malignant lesions because of the lack of characteristic features. We present the case of a 32-year-old man that was misdiagnosed as intrahepatic cholangiocarcinoma by CECT, CEMRI, and CEUS, which was finally confirmed as IPT by fine-needle liver biopsy. In this report, the key factor in the diagnosis of liver inflammatory masses was the presence of hepatic perfusion disorder.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/87/98/main.PMC9617152.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40657949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of Interventional Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1